The Drivers of Acute and Long-term Care Clostridium difficile Infection Rates: A Retrospective Multilevel Cohort Study of 251 Facilities

Clin Infect Dis. 2017 Oct 15;65(8):1282-1288. doi: 10.1093/cid/cix532.

Abstract

Background: Drivers of differences in Clostridium difficile incidence across acute and long-term care facilities are poorly understood. We sought to obtain a comprehensive picture of C. difficile incidence and risk factors in acute and long-term care.

Methods: We conducted a case-cohort study of persons spending at least 3 days in one of 131 acute care or 120 long-term care facilities managed by the United States Veterans Health Administration between 2006 and 2012. Patient (n = 8) and facility factors (n = 5) were included in analyses. The outcome was the incidence of facility-onset laboratory-identified C. difficile infection (CDI), defined as a person with a positive C. difficile test without a positive test in the prior 8 weeks.

Results: CDI incidence in acute care was 5 times that observed in long-term care (median, 15.6 vs 3.2 per 10000 person-days). History of antibiotic use was greater in acute care compared to long-term care (median, 739 vs 513 per 1000 person-days) and explained 72% of the variation in C. difficile rates. Importation of C. difficile cases (acute care: patients with recent long-term care attributable infection; long-term care: residents with recent acute care attributable infection) was 3 times higher in long-term care as compared to acute care (median, 52.3 vs 16.2 per 10000 person-days).

Conclusions: Facility-level antibiotic use was the main factor driving differences in CDI incidence between acute and long-term care. Importation of acute care C. difficile cases was a greater concern for long-term care as compared to importation of long-term care cases for acute care.

Keywords: Clostridium difficile infection; antimicrobials; healthcare associated infection; inter-facility patient transfer; transmission.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use
  • Clostridioides difficile
  • Clostridium Infections / drug therapy
  • Clostridium Infections / epidemiology*
  • Cross Infection / drug therapy
  • Cross Infection / epidemiology*
  • Female
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Multilevel Analysis
  • Patient Transfer
  • Retrospective Studies
  • Risk Factors
  • Treatment Outcome
  • United States / epidemiology

Substances

  • Anti-Bacterial Agents